166
Participants
Start Date
April 30, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
April 30, 2017
Anlotinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Chinese PLA General Hospital, Beijing
The 1st affiliated hospital of bengbu medical college, Bengbu
Beijing Cancer Hospital, Beijing
Beijing Jishuitan Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Fujian Province Cancer Hospital, Fuzhou
The First Affiliated Hospital of Fujian Meidical University, Fuzhou
Gansu Province Tumor Hospital, Lanzhou
Sun Yat-Sen University Cancer Center, Guangzhou
Guangxi medical university affiliated tumor hospital, Nanning
Harbin medical university affiliated tumor hospital, Harbin
Liaoning Province Tumor Hospital, Shenyang
Cancer Hospital of Fudan University, Shanghai
Shanghai 6th People's Hospital, Shanghai
Tianjin Medical University Cancer Hospital, Tianjin
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY